D-0460-2025 Class II Ongoing
FDA drug recall D-0460-2025 was initiated by AvKARE on May 13, 2025 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules The recall status is ongoing. Affected quantity: 3,817 50-count cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 18, 2025
- Initiation Date
- May 13, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,817 50-count cartons
Product description
Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-169-15
Reason for recall
Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules
Distribution pattern
Nationwide in the USA
Code information
Lot #47881, Exp 05/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0460-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026